Mather Group’s Encompass Health EHC Stock Holding History

Mather Group’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3K	Hold	122	–	–	﹤0.01%	1448
2026 Q1	$11.8K	Buy	+122	New	+$12.5K	﹤0.01%	1404

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mather Group's EHC Position: Q2 2026 in Review

Mather Group held its Encompass Health (EHC) position steady in Q2 2026 at 122 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Mather Group first reported a position in EHC in Q1 2026 and has held it in 2 quarters since. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

Mather Group held 122 shares of Encompass Health worth $12.3K as of Q2 2026.
Mather Group left its Encompass Health share count unchanged in Q2 2026.
Encompass Health made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1448 holding.
Mather Group first reported a position in Encompass Health in Q1 2026 and has held it in 2 quarters since.
599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.